Review Article
A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
Table 1
Summary of included 18F-FDG-PET for early diagnosis and conversion prediction, with LHR, increase in LHR+, GRADE, and population.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total number of patients and healthy controls considered in the study. Method: quantitative method applied in the study. Cohort investigated: number of patients considered for sensitivity and specificity estimations. Followup: duration of observational period (for early diagnosis study). Sensitivity and specificity: results of the study. LHR+: likelihood ratio. Increase in the LHR+: increase in the probability of the likelihood of the disease. GRADE: results of GRADE evaluation. Quality of evidence was evaluated based on LHR+ values, LHR+ increase probability, and size of the sample included. Abbreviations: pAD: probable Alzheimer’s disease; MCI: mild cognitive impairment; aMCI: amnestic mild cognitive impairment; MCIc: MCI converters; MCIs: MCI stable; HC: healthy controls. *Studies including early diagnosis of AD. |